Coherus BioSciences' IPO

Coherus BioSciences raised a round of funding on November 06, 2014. Investors include Public.

Coherus is a biologics platform company focused on delivering high-quality biosimilar therapeutics that will expand patient access to life-changing medications worldwide. Headquartered in the San Fran…

Articles about Coherus BioSciences' IPO: